Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH)

Conditions:   Pregnancy, High Risk;   Anticoagulants Intervention:   Drug: Lovenox Sponsor:   University of California, Irvine Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Lovenox | Pregnancy | Research | Women